How Do Melanoma Comorbidities Affect Patient Treatment Preferences?
Patients may have different preferences for treatment outcomes and processes based on existing comorbidities.
Skin Cancer
SKIN CANCER
FEATURE ARTICLE
LATEST NEWS
AI Model May Predict Immunotherapy Response in Melanoma
An algorithm that combines deep learning on histology slides and patient clinical data may predict immune checkpoint inhibitor response in patients with advanced melanoma.
Medicaid Expansion Tied to Increased Detection of Early Cancers
Medicaid expansion under the ACA was associated with an increase in early-stage cancer diagnoses in the first year after expansion and a decrease in late-stage cancer diagnoses 3 years after expansion.
Military Personnel Have Greater Risk Factors for Cutaneous Cancer
Significant risk factors for developing cutaneous cancer in active-duty military personnel was explored and compared with that of the general population.
New Cancer Drug Approvals Linked to Drop in Mortality
For the most common cancers, cancer drug approvals between 2000 and 2016 were associated with a reduction in deaths.
Higher Mortality Among COVID-19 Patients with Cancer
Investigators compared the clinical course, risk factors, and outcomes of cancer patients with COVID-19 with non-cancer patients with COVID-19.
BEMPEG Plus Nivolumab Induces Durable Responses in Metastatic Melanoma
BEMPEG combined with nivolumab resulted in deep and durable responses among patients with treatment-naive metastatic melanoma, according to phase 2 data.
Broader Genetic Testing Could ID More Heritable Cancers
Universal multigene panel testing for patients with solid tumor cancer increases detection of heritable variants over the predicted yield of guideline-based testing.
Risk of Melanoma Measured in Mutation Burden of Skin Cells
Mutation count could offer personal screening guidelines.
Dabrafenib Plus Trametinib Improves Survival Without Relapse, Distant Metastasis in Stage 3 Melanoma
The long-term stability of the relapse-free survival benefit of adjuvant therapy with dabrafenib plus trametinib in treating patients with stage melanoma was evaluated.
Scalp at High Risk for Cutaneous Squamous Cell Carcinoma Metastasis
Investigators sought to quantify the metastatic risk for cSCC on the scalp vs lip or ear.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Skin Cancer
